Laboratory Mixer Market Size, Share & Trends Analysis Report By Product (Shakers, Vortex Mixers), By End Use (Pharmaceutical And Biotechnology Companies, Research Laboratories And Institutes), By Region, And Segment Forecasts, 2024 - 2030

Laboratory Mixer Market Size, Share & Trends Analysis Report By Product (Shakers, Vortex Mixers), By End Use (Pharmaceutical And Biotechnology Companies, Research Laboratories And Institutes), By Region, And Segment Forecasts, 2024 - 2030


Laboratory Mixer Market Size & Trends

The global laboratory mixer market size was estimated at USD 2.29 billion in 2023 and is expected to grow at a CAGR of 3.2% from 2024 to 2030. This growth is attributed to increasing demand for laboratory mixers used in research and development processes in pharmaceutical, biotechnology, and chemical industries. Furthermore, increasing demand for efficient and precise mixing solutions coupled with the development of more efficient and automated systems drives the market growth by improving mixing accuracy, speed, and scalability. The increasing healthcare expenditure and funding on research are likely to drive the market over the forecast period.

The market is witnessing a shift towards more efficient and automated systems, which is a significant driver for growth. Manufacturers are developing laboratory mixers and shakers with advanced features such as programmable controls, data logging capabilities, and integration with laboratory information management systems (LIMS). These automated systems reduce human error, increase productivity, and allow for more standardized processes. The trend towards high-throughput screening and parallel processing in research is also driving the demand for mixers that can handle multiple samples simultaneously. For instance, in August 2022, Admix, Inc. introduced the Benchmix 10, a compact high shear lab mixer featuring the patented Admix Rotosolver high shear mix head. This design is optimized for effectively wetting out and dispersing powders, eliminating agglomerates, and producing uniform mixtures and emulsions.

Additionally, the integration of Internet of Things (IoT) technology and artificial intelligence in laboratory equipment is enabling remote monitoring and control, predictive maintenance, and more efficient resource utilization, further boosting the appeal of modern laboratory mixer.

The pharmaceutical and biotechnology industries have seen a surge in research activities, driving a growing demand for various laboratory equipment in recent years. This trend is expected to continue, as laboratory mixers play a crucial role in research laboratories. However, small and medium-sized laboratories often face financial constraints, limiting their ability to invest in high-performance mixers, which can cost upwards of USD 7,000. In contrast, basic mixers are more affordable, priced under USD 500. This significant price difference has hindered the adoption of advanced mixers in smaller laboratories. Furthermore, laboratory mixers are built to last, with proper maintenance and operation extending their lifespan up to ten years. This durability reduces the need for frequent equipment replacements, making them a valuable investment for research teams.

Technological advancements are playing a crucial role in driving the market, particularly in the realm of laboratory mixer. Innovations in materials science have led to the development of mixers with improved durability, chemical resistance, and temperature tolerance, expanding their applications in various research fields. For instance, in June 2022, IKA introduced the groundbreaking convertible mixing device, the IKA TWISTER. This innovative device can function as a single-position magnetic stirrer or a multi-position magnetic stirrer, offering great flexibility. With one attachment, it can effectively stir small volumes, while with another attachment, it transforms into a vortex shaker. Moreover, Grant Bio Mini Magnetic Stirrer MMS-3000 provided by Grant instruments is a compact and versatile instrument designed for efficient stirring of small volumes in everyday laboratory applications, including pH measurements, extractions, and dialysis procedures. The integration of digital technologies has resulted in mixers with enhanced precision, real-time monitoring capabilities, and data analytics features. Advancements in microfluidics and nanotechnology are driving the development of miniaturized mixing systems for applications in point-of-care diagnostics and personalized medicine.

The rise in healthcare expenditure and increased funding for research activities are significant drivers for the laboratory mixer market. Governments, private organizations, and academic institutions are allocating more resources to healthcare research, drug discovery, and development of new therapies. According to a Science and Engineering Indicators in 2022, research and development (R&D) spending in the U. S. totaled an estimated $885.6 billion in current U.S. dollars. This represents a 12% increase from 2021 in nominal dollars and a 5% increase in inflation-adjusted dollars. The article further highlighted the growing role of the business sector in funding and performing U.S. R&D, especially in basic and applied research.

Global Laboratory Mixer Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global laboratory mixer market report based on product, end use, and region:
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Shakers
  • Orbital Shakers
  • Rollers/Rotators
  • Other Product Types
  • Vortex Mixers
  • Magnetic Stirrers
  • Accessories
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical and Biotechnology Companies
  • Research Laboratories and Institutes
  • Other End Use
  • Regional Outlook (Revenue in USD Million, 2018 - 2030)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Laboratory Mixer Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing use in research and development processes
3.2.1.2. Technological advancements
3.2.1.3. Growing demand for efficient and precise mixing solutions
3.2.1.4. Increasing healthcare expenditure and funding on research
3.2.2. Market restraints analysis
3.2.2.1. High cost of advanced laboratory mixers
3.3. Laboratory Mixer Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Laboratory Mixer Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Laboratory Mixer Market Product Movement Analysis
4.3. Global Laboratory Mixer Materials Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Shakers
4.4.1. Shakers market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Orbital Shakers
4.4.2.1. Orbital Shakers market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Rollers/Rotators
4.4.3.1. Rollers/Rotators market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Other Product Types
4.4.4.1. Other Product Types market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Vortex Mixers
4.5.1. Vortex Mixers market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Magnetic Stirrers
4.6.1. Magnetic Stirrers market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Accessories
4.7.1. Accessories market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Laboratory Mixer Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Laboratory Mixer Market End Use Movement Analysis
5.3. Global Laboratory Mixer Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Pharmaceutical and Biotechnology Companies
5.4.1. Pharmaceutical and Biotechnology Companies market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Research Laboratories and Institutes
5.5.1. Research Laboratories and Institutes market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Other End Use
5.6.1. Other End Use market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Laboratory Mixer Market: Regional Estimates & Trend Analysis By Product, and By End Use
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. U.S.
6.4.1.1. Key country dynamics
6.4.1.2. Competitive scenario
6.4.1.3. Regulatory framework
6.4.1.4. Target disease prevalence
6.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Canada
6.4.2.1. Key country dynamics
6.4.2.2. Competitive scenario
6.4.2.3. Regulatory framework
6.4.2.4. Target disease prevalence
6.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Mexico
6.4.3.1. Key country dynamics
6.4.3.2. Competitive scenario
6.4.3.3. Regulatory framework
6.4.3.4. Target disease prevalence
6.4.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Europe
6.5.1. UK
6.5.1.1. Key country dynamics
6.5.1.2. Competitive scenario
6.5.1.3. Regulatory framework
6.5.1.4. Target disease prevalence
6.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Germany
6.5.2.1. Key country dynamics
6.5.2.2. Competitive scenario
6.5.2.3. Regulatory framework
6.5.2.4. Target disease prevalence
6.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. France
6.5.3.1. Key country dynamics
6.5.3.2. Competitive scenario
6.5.3.3. Regulatory framework
6.5.3.4. Target disease prevalence
6.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Italy
6.5.4.1. Key country dynamics
6.5.4.2. Competitive scenario
6.5.4.3. Regulatory framework
6.5.4.4. Target disease prevalence
6.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. Spain
6.5.5.1. Key country dynamics
6.5.5.2. Competitive scenario
6.5.5.3. Regulatory framework
6.5.5.4. Target disease prevalence
6.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Norway
6.5.6.1. Key country dynamics
6.5.6.2. Competitive scenario
6.5.6.3. Regulatory framework
6.5.6.4. Target disease prevalence
6.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.5.7. Sweden
6.5.7.1. Key country dynamics
6.5.7.2. Competitive scenario
6.5.7.3. Regulatory framework
6.5.7.4. Target disease prevalence
6.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key country dynamics
6.5.8.2. Competitive scenario
6.5.8.3. Regulatory framework
6.5.8.4. Target disease prevalence
6.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key country dynamics
6.6.1.2. Competitive scenario
6.6.1.3. Regulatory framework
6.6.1.4. Target disease prevalence
6.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. China
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Target disease prevalence
6.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. India
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Target disease prevalence
6.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Australia
6.6.4.1. Key country dynamics
6.6.4.2. Competitive scenario
6.6.4.3. Regulatory framework
6.6.4.4. Target disease prevalence
6.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key country dynamics
6.6.5.2. Competitive scenario
6.6.5.3. Regulatory framework
6.6.5.4. Target disease prevalence
6.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Thailand
6.6.6.1. Key country dynamics
6.6.6.2. Competitive scenario
6.6.6.3. Target disease prevalence
6.6.6.4. Regulatory framework
6.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key country dynamics
6.7.1.2. Competitive scenario
6.7.1.3. Regulatory framework
6.7.1.4. Target disease prevalence
6.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. Argentina
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Target disease prevalence
6.7.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key country dynamics
6.8.1.2. Competitive scenario
6.8.1.3. Regulatory framework
6.8.1.4. Target disease prevalence
6.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Saudi Arabia
6.8.2.1. Key country dynamics
6.8.2.2. Competitive scenario
6.8.2.3. Regulatory framework
6.8.2.4. Target disease prevalence
6.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. UAE
6.8.3.1. Key country dynamics
6.8.3.2. Competitive scenario
6.8.3.3. Regulatory framework
6.8.3.4. Target disease prevalence
6.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.8.4. Kuwait
6.8.4.1. Key country dynamics
6.8.4.2. Competitive scenario
6.8.4.3. Regulatory framework
6.8.4.4. Target disease prevalence
6.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company/Competition Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2023
7.4. Company Profiles/Listing
7.4.1. IKA-Werke
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Eppendorf
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Thermo Fisher Scientific
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Shuanglong Group Co. Ltd
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Bio-Rad Laboratories Inc.
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. REMI GROUP
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Benchmark Scientific Inc.
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Silverson
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. SARSTEDT AG & Co. KG
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Antylia Scientific
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Corning Incorporated
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Labstac Ltd
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings